Lifestyle
- Increase physical activity
- Reduce stress levels
- Quit smoking
Omega-3 Index · EPA+DHA Index · Fatty Acid Status
The Omega-3 Index measures the percentage of EPA and DHA in red blood cell membranes.
Ranges are general and may vary based on population studies.
The Omega-3 Index is a biomarker that quantifies the percentage of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in the membranes of red blood cells (RBCs). This index reflects the long-term dietary intake of omega-3 fatty acids and is considered a reliable indicator of an individual's omega-3 status. Researchers use the Omega-3 Index to assess the risk of various health conditions, including cardiovascular diseases and psychiatric disorders. Clinically, a higher Omega-3 Index is associated with a reduced risk of sudden cardiac death (SCD), myocardial infarction, and certain mental health conditions such as depression and dementia. In the context of athletic performance and biohacking, maintaining an optimal Omega-3 Index may support cognitive function, reduce inflammation, and enhance recovery. However, the index can be influenced by factors such as dietary intake, genetic variability, and the presence of chronic diseases. It is important to consider these confounders when interpreting results. The Omega-3 Index does not require fasting and is not time-of-day sensitive, making it a convenient marker for routine monitoring.
Klinische Bedeutung
Elevated Omega-3 Index values are associated with a reduced risk of sudden cardiac death and improved cardiovascular health. Lower values may indicate an increased risk of cardiovascular diseases and certain psychiatric disorders.
Progressively rising values suggest improved cardiovascular and cognitive health. Re-test annually to monitor changes.
Progressively falling values may indicate increased cardiovascular risk or dietary insufficiency.
Re-test Interval
6 months if outside optimal range
Note:
Consult a healthcare provider before starting any new supplementation, especially if you have underlying health conditions.
Testing Frequency
Annually for general health monitoring, more frequently if managing specific health conditions.
Current research suggests that optimal target ranges for the Omega-3 Index remain debated, particularly regarding specific thresholds for various psychiatric conditions and cardiovascular risks. Researchers have not yet established standardized reference ranges across diverse populations, which may confound interpretations of the biomarker's significance. Additionally, clinical questions remain unanswered about the long-term effects of varying Omega-3 Index levels on mental health outcomes and the mechanisms underlying its association with cardiovascular risk.
673
Total Citations
9
Human/RCT
5.4
Avg. Influence
2024
Latest
This study highlighted the clinical significance of the Omega-3 Index in assessing risk for sudden cardiac death. Researchers noted that low levels of EPA and DHA in erythrocytes are linked to increased risk. The optimal Omega-3 Index level is suggested to be 8% or greater.
von Schacky Clemens · Nutrients · 2021
This study examined the relationship between blood levels of EPA and DHA and brain health. Researchers found that lower Omega-3 Index levels were linked to increased risks of mortality, stroke, and cognitive decline. The optimal Omega-3 Index is suggested to be between 8-11%.
Key findings
This review examined the Omega-3 Index as a potential risk marker for coronary heart disease. Researchers found that the Omega-3 Index fulfills many criteria to be considered a risk factor for heart disease, particularly sudden cardiac death.
Schuchardt Jan Philipp, et al. · Progress in lipid research · 2024
This study updated the global Omega-3 Index (O3I) map, revealing that most countries have low to very low O3I levels. Researchers found notable improvements in countries like Finland and Iceland, while others like Iran and India showed particularly poor levels. The O3I is defined as the percentage of EPA and DHA in red blood cell membranes.
Key findings
Researchers proposed the Omega-3 Index as a potential risk factor for sudden cardiac death (SCD). The study indicated a significant relationship between lower O3I levels and increased risk for SCD. The O3I can be measured through standardized laboratory procedures.
This study aimed to estimate the Omega-3 Index in the UK Biobank and identify predictors of its levels. Researchers found that oily fish consumption and demographic factors significantly correlated with Omega-3 Index levels, with a mean estimated O3I of 5.58%.
This article discussed the correlation between Omega-3 Index levels and cardiovascular disease risk. Researchers found that individuals with an O3I below 4% had a tenfold higher risk of sudden cardiac death compared to those with levels above 8%. Dietary intake of EPA and DHA was shown to reduce cardiovascular events.
In studies on lupus, researchers found that higher Omega-3 Index levels were associated with reduced indicators of autoimmune activity. They identified thresholds for Omega-3 levels that could be targeted in future human studies to potentially lessen lupus symptoms. The findings suggest a link between Omega-3 consumption and autoimmune disease management.
In a cohort study of heart failure patients, researchers observed that the Omega-3 Index was markedly low and did not predict mortality risk. The study indicated weak associations between Omega-3 levels and various clinical characteristics of heart failure, suggesting further research is needed to clarify these relationships.
This study explored the Omega-3 Index as a biomarker in sports medicine. Researchers found that maintaining an optimal O3I may benefit cardiovascular health and athletic performance, suggesting its role in recovery and injury prevention for athletes.
1
Total Trials
800
Total Enrolled
Universidad de Granada
800
2025
omega-3 index
Research publications about Omega-3-Index over time
10totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer